Stephen Squinto, Ph.D., Executive Vice President, Chief Global Operations Officer
Stephen Squinto, Ph.D. is co-founder of Alexion Pharmaceuticals and currently serves as Executive Vice President and Chief Global Operations Officer.
is responsible for Alexion's Global Quality, Manufacturing and Project Management functions.
Since co-founding Alexion
with CEO Leonard Bell in 1992, Dr. Squinto
has held several leadership positions guiding the company's research and development programs across the Alexion pipeline, including Executive Vice President, Head of R&D, during which he
led the Company's program that resulted in Soliris ® approvals for patients with atypical hemolytic uremic syndrome in the US, European Union and Japan
Prior to co-founding Alexion, Dr. Squinto held various scientific positions at Regeneron Pharmaceuticals, Inc., focused on drug discovery.
He has also served as Assistant Professor of Biochemistry and Molecular Biology at Louisiana State University Medical Center.
Dr. Squinto is a prominent researcher in molecular and cellular biology, with more than 70 scientific papers resulting from his work.
He also serves on the Board of Directors of the regional Chapter of the Juvenile Diabetes Research Foundation.
Dr. Squinto received a bachelor's degree in chemistry and a doctorate degree in biochemistry and biophysics from Loyola University in Chicago.